Hawkins (NASDAQ:HWKN) Director James Faulconbridge Purchases 1,500 Shares

February 7, 2026 by InsiderTrades.com

Key Points

Director James Faulconbridge bought 1,500 shares at an average of $129.29 on Feb. 4, increasing his stake to 50,907 shares (a 3.04% rise) valued at about $6.58 million, a purchase that coincided with the stock rising roughly 3.4%.
Hawkins missed quarterly expectations, reporting $0.72 EPS vs. $0.75 expected and revenue of $244.08 million vs. $252.51 million, and the stock carries a consensus analyst rating of "Hold" with an average target of $162.50.
The company declared a quarterly dividend of $0.19 per share (ex-dividend Feb. 13, payable Feb. 27), equal to a $0.76 annualized payout and about a 0.6% yield with a payout ratio near 19.2%.

Hawkins, Inc. (NASDAQ:HWKN - Get Free Report) Director James Faulconbridge bought 1,500 shares of the company's stock in a transaction that occurred on Wednesday, February 4th. The stock was purchased at an average cost of $129.29 per share, with a total value of $193,935.00. Following the acquisition, the director directly owned 50,907 shares in the company, valued at $6,581,766.03. This trade represents a 3.04% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Hawkins Stock Up 3.4%

HWKN opened at $134.38 on Friday. The company has a quick ratio of 1.46, a current ratio of 2.35 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $2.81 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 2.75 and a beta of 0.86. Hawkins, Inc. has a 52 week low of $98.30 and a 52 week high of $186.15. The firm has a 50-day simple moving average of $144.54 and a two-hundred day simple moving average of $155.17.

Hawkins (NASDAQ:HWKN - Get Free Report) last issued its quarterly earnings data on Wednesday, January 28th. The specialty chemicals company reported $0.72 EPS for the quarter, missing analysts' consensus estimates of $0.75 by ($0.03). The business had revenue of $244.08 million during the quarter, compared to analysts' expectations of $252.51 million. Hawkins had a return on equity of 16.85% and a net margin of 7.75%. Analysts forecast that Hawkins, Inc. will post 4 earnings per share for the current fiscal year.

Hawkins Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be paid a dividend of $0.19 per share. The ex-dividend date is Friday, February 13th. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. Hawkins's dividend payout ratio (DPR) is currently 19.24%.

Wall Street Analyst Weigh In

HWKN has been the subject of several recent analyst reports. BWS Financial reiterated a "buy" rating and set a $200.00 price objective on shares of Hawkins in a research note on Thursday, January 29th. Zacks Research upgraded Hawkins from a "strong sell" rating to a "hold" rating in a research report on Friday, January 2nd. Finally, Weiss Ratings lowered Hawkins from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Monday, January 12th. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $162.50.

Check Out Our Latest Stock Analysis on HWKN

More Hawkins News

Here are the key news stories impacting Hawkins this week:

Positive Sentiment: Director James A. Faulconbridge increased his stake, purchasing 1,500 shares at an average $129.29 (total ~$193,935), bringing his holdings to ~50,907 shares (worth ~ $6.58M). Insider buying by a director is typically viewed as a confidence signal and likely helped lift the stock. Top Insider Just Made a Big Bet on This Under-the-Radar Company SEC Form 4
Neutral Sentiment: Reported short interest shows 0 shares and a 0.0 days-to-cover ratio — this appears to be a reporting artifact or a very low short interest reading. Low/zero short interest reduces short-squeeze risk but offers limited directional insight. (Source: market data entry)
Negative Sentiment: Sidoti (coverage) trimmed its FY2027 EPS estimate for Hawkins from $5.10 to $4.60 and published a cautious near-term view; the firm projects FY2028 at $5.10 and Q3 2028 at $1.01. Analyst downgrades can pressure the stock by lowering near-term expectations and investor sentiment. Sidoti Csr Has Pessimistic View of Hawkins FY2026 Earnings

Hedge Funds Weigh In On Hawkins

Large investors have recently made changes to their positions in the stock. Capital World Investors boosted its holdings in Hawkins by 618.8% in the third quarter. Capital World Investors now owns 355,619 shares of the specialty chemicals company's stock valued at $64,979,000 after purchasing an additional 306,143 shares during the period. Invesco Ltd. increased its stake in Hawkins by 44.4% in the 3rd quarter. Invesco Ltd. now owns 407,793 shares of the specialty chemicals company's stock valued at $74,512,000 after buying an additional 125,444 shares during the period. Schroder Investment Management Group raised its stake in shares of Hawkins by 130.7% during the 2nd quarter. Schroder Investment Management Group now owns 149,397 shares of the specialty chemicals company's stock worth $21,229,000 after buying an additional 84,651 shares in the last quarter. Granite Investment Partners LLC purchased a new position in shares of Hawkins in the 3rd quarter valued at about $11,610,000. Finally, Segall Bryant & Hamill LLC raised its holdings in Hawkins by 76.1% during the second quarter. Segall Bryant & Hamill LLC now owns 112,431 shares of the specialty chemicals company's stock worth $15,976,000 after purchasing an additional 48,602 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors and hedge funds.

Hawkins Company Profile

(Get Free Report)

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins' product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.